Home › Funds › Sofinnova Investments, Inc. › INSM

Sofinnova Investments, Inc. position in INSM

INSMED INC · Health Care

Sofinnova Investments, Inc. reported holding 158,398 shares of INSM (INSMED INC) in its Q2 2026 13F filing — a position valued at US$16.9M, representing 0.90% of its reported portfolio and ranking #28 among its reported holdings. Sofinnova Investments, Inc. has disclosed INSM holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)158.40K sh
Reported value held$16.89M
Portfolio Weight0.90%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sofinnova Investments, Inc.'s INSM position evolved

Sofinnova Investments, Inc. first disclosed a stake in INSM in Q1 2024 at 100,000 shares (US$2.7M). The position peaked in Q1 2026 at 346,075 shares, worth US$56.6M. Across 10 filings, Sofinnova Investments, Inc. increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 158,398 shares valued at US$16.9M — a reduction of -187,677 shares quarter over quarter.. Notable position changes include a 128% increase in Q2 2024 (shares rose 8% over the following quarter), a 67% trim in Q3 2025 (shares rose 24% over the following quarter), a 121% increase in Q1 2026 (shares fell 38% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 100.00K $2.71M New
Q2 2024 227.75K $15.26M Add
Q3 2024 286.31K $20.90M Add
Q4 2024 256.28K $17.69M Reduce
Q1 2025 304.25K $23.21M Add
Q2 2025 313.92K $31.59M Add
Q3 2025 104.34K $15.03M Reduce
Q4 2025 156.80K $27.29M Add
Q1 2026 346.07K $56.59M Add
Q2 2026 158.40K $16.89M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 40 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$937.8M), Darwin Global Management, Ltd. (US$673.6M), Orbis Allan Gray Ltd (US$647.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has Sofinnova Investments, Inc. held INSM?

Sofinnova Investments, Inc. has disclosed INSM holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is Sofinnova Investments, Inc.'s current position in INSM?

As of Q2 2026, Sofinnova Investments, Inc. holds 158.40K shares of INSM (INSMED INC), valued at $16.89M, representing 0.90% of its reported portfolio and ranking #28.

Has Sofinnova Investments, Inc. been buying or selling INSM?

In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. reduced its position in INSM. The position peaked in Q1 2026 at 346.07K shares.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., Orbis Allan Gray Ltd, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.